Skip to Main Content


Skip Nav Destination

A Randomized Phase II and Pharmacokinetic Study of the Antisense Oligonucleotides ISIS 3521 and ISIS 5132 in Patients with Hormone-refractory Prostate Cancer1

Clin Cancer Res (2002) 8 (8): 2530–2535.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal